SCHEMBL4604987

SCHEMBL4604987

O=C(O)C(=O)/C=C/c1cc(Br)cs1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
GAA P10253 1/20 0.40
RAB9A P51151 1/20 0.40
KCNA3 P22001 1/20 0.40
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
GABBR2 O75899 1/20 0.37
GABBR1 Q9UBS5 1/20 0.37
MAPT P10636 1/20 0.35
LMNA P02545 3/20 0.34
HCAR2 Q8TDS4 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
GSK3B P49841 1/20 0.34
POLB P06746 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
EIF2AK2 P19525 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4604993 1.00 NPC1 (0.40) NPC1MEN1KMT2AGAARAB9A
SCHEMBL380483 0.85 HCAR2 (0.48) NPC1MEN1KMT2AGAARAB9A
SCHEMBL380484 0.85 HCAR2 (0.48) NPC1MEN1KMT2AGAARAB9A
SCHEMBL7890262 0.79 CES2 (0.41) NPC1MEN1KMT2AGAARAB9A
SCHEMBL7890266 0.79 CES2 (0.41) NPC1MEN1KMT2AGAARAB9A
SCHEMBL1904086 0.75 KCNA3 (0.46) NPC1MEN1KMT2AGAARAB9A
SCHEMBL4081161 0.75 KCNA3 (0.46) NPC1MEN1KMT2AGAARAB9A
SCHEMBL1904084 0.75 KCNA3 (0.46) NPC1MEN1KMT2AGAARAB9A
SCHEMBL2491537 0.75 NPC1 (0.40) NPC1MEN1KMT2AGAARAB9A
SCHEMBL2491542 0.75 NPC1 (0.40) NPC1MEN1KMT2AGAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1946777-A1 Substituted pyrazoline for preventing weight gain Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP disclosed
EP-1946777-A1 Substituted pyrazoline for preventing weight gain Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP disclosed
EP-1946778-A1 Active substance combination for the treatment of diabetes Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP disclosed
EP-1946778-A1 Active substance combination for the treatment of diabetes Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP disclosed
WO-2007009690-A1 HETEROCYCLYL-SUBSTITUTED PYRAZOLINE COMPOUNDS, THEIR PREPARATION AND USE AS MEDICAMENTS LABORATORIOS DEL DR. ESTEVE, S.A (ES) 2007-01-25 WO disclosed
WO-2007009690-A1 HETEROCYCLYL-SUBSTITUTED PYRAZOLINE COMPOUNDS, THEIR PREPARATION AND USE AS MEDICAMENTS LABORATORIOS DEL DR. ESTEVE, S.A (ES) 2007-01-25 WO disclosed
EP-1743894-A1 Heterocyclyl-substituted pyrazoline compounds, their preparation and use as medicaments LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-01-17 EP disclosed
EP-1743894-A1 Heterocyclyl-substituted pyrazoline compounds, their preparation and use as medicaments LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-01-17 EP disclosed